Literature DB >> 2264841

Platelets and thrombolytic therapy.

B S Coller1.   

Abstract

Mesh：

Substances：

Year:  1990        PMID： 2264841     DOI： 10.1056/NEJM199001043220107

Source DB:  PubMed          Journal:  N Engl J Med        ISSN： 0028-4793            Impact factor:   91.245


× No keyword cloud information.
  52 in total

Review 1.  Platelet glycoprotein IIb/IIIa inhibitors combined with fibrinolytic agents to treat acute myocardial infarction.

Authors:  P L L'Allier; A M Lincoff
Journal:  J Thromb Thrombolysis       Date:  2001-02       Impact factor: 2.300

Review 2.  New advances in the management of acute coronary syndromes: 2. Fibrinolytic therapy for acute ST-segment elevation myocardial infarction.

Authors:  P W Armstrong
Journal:  CMAJ       Date:  2001-09-18       Impact factor: 8.262

Review 3.  Platelet aggregation inhibition with glycoprotein IIb--IIIa inhibitors.

Authors:  G Proimos
Journal:  J Thromb Thrombolysis       Date:  2001-04       Impact factor: 2.300

Review 4.  Platelet activation in acute myocardial infarction and the rationale for combination therapy.

Authors:  I Conde-Pozzi; N Kleiman
Journal:  Curr Cardiol Rep       Date:  2000-09       Impact factor: 2.931

Review 5.  Glycoprotein receptor inhibitors in the management of acute coronary syndromes.

Authors:  Henock Saint-Jacques; And Robert A Harrington
Journal:  Curr Cardiol Rep       Date:  2002-07       Impact factor: 2.931

6.  [The experimental investigation on the preventive effects of API0134 against the re-occlusion of coronary arteries after therapeutic thrombolysis in dogs].

Authors:  S Li; H Zhao; Z Guo
Journal:  J Tongji Med Univ       Date:  1999

7.  Characterization of human 12-lipoxygenase genes.

Authors:  C D Funk; L B Funk; G A FitzGerald; B Samuelsson
Journal:  Proc Natl Acad Sci U S A       Date:  1992-05-01       Impact factor: 11.205

Review 8.  New anticoagulant strategies. Current status and future potential.

Authors:  J Weitz
Journal:  Drugs       Date:  1994-10       Impact factor: 9.546

9.  Comparative effects of anti-platelet agents as adjuncts to tissue plasminogen activator in a dog model of occlusive coronary thrombosis.

Authors:  S J McAuliffe; J A Moors; H B Jones
Journal:  Br J Pharmacol       Date:  1994-05       Impact factor: 8.739

Review 10.  Platelet glycoprotein IIb/IIIa inhibitors in percutaneous coronary intervention: focus on the pharmacokinetic-pharmacodynamic relationships of eptifibatide.

Authors:  Ian C Gilchrist
Journal:  Clin Pharmacokinet       Date:  2003       Impact factor: 6.447
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.